GO
| HSI1 | 26,405.75 | +44.68 | 8.03B |
| HSCEI1 | 8,917.54 | +18.48 | 1.80B |
| Back Zoom + Zoom - Block Traded | |
|
INSILICO Soars 17% as AI Framework for Drug Target Discovery Makes New Progress
2026-04-20 11:40:06 INSILICO (03696.HK) opened up 0.08% this morning (20th) and once peaked at HKD71.4. It last traded at HKD71.3, up 17.27%, with a volume of 6.2793 million shares, involving HKD426 million. The company announced that it had integrated its previously launched Target Identification Pro (TargetPro) and Target Identification Benchmark (TargetBench 1.0) into a framework that can further validate druggability. According to the research results recently published by INSILICO in Scientific Reports, this framework delivered outstanding results in both benchmark testing and real-world target discovery workflows, further demonstrating its value as a standardized foundation for AI-driven target identification. In addition, TIGERMED (03347.HK) has signed a strategic cooperation agreement with INSILICO, under which the two parties will engage in long-term strategic collaboration on clinical research for innovative drug products, leveraging AI to accelerate and enhance the efficiency of drug development. ~ AAStocks Financial News Web Site: www.aastocks.com | |